GDP Audits : Weak points when conducting GDP Audit based on inspections

Size: px
Start display at page:

Download "GDP Audits : Weak points when conducting GDP Audit based on inspections"

Transcription

1 GDP Audits : Weak points when conducting GDP Audit based on inspections s COOL SUPPLY System & Solutions 2017 Webinar 15 February 2017 Riekert Bruinink Dutch Healthcare Inspectorate

2 2 Titel van presentatie datum van presentatie

3 AGENDA 1. GDP inspection practice 2. Review of GDP and GDP/GMP inspections - Quality management issues - Responsible Person /training - Temperature management storage / returns - Qualification / outsourcing / transportation 3

4 1. Introduction EU GDP Guidelines Publication new EU GDP guide: 7 th March 2013 Implementation period : 6 months (until 8 September 2013) Publication new version EU GDP Guidelines ( corrections text and translation errors) 4

5 1.GDP Inspection process in general Frequency of GDP inspections Planning (can be risk based) How many and which topics are inspected? It isn t possible to inspect everything Announced / unannounced inspections How long? How many inspectors? 5 Titel van presentatie datum van presentatie

6 1. GDP Inspection process Announcement inspection by a letter Confirmation Request for some documents (SMF/ QMS/Products) inspection - introduction - developments / changes since last inspection - organization / position RP - follow-up previous inspection 6 Titel van presentatie datum van presentatie

7 1. GDP inspection process making programme walking around : inspecting facilities (e.g. entrance, routing of goods, receive,storage /temperature / dispatch ) verification registrations / documents summing up ( critical /major /minor deficiencies) 7 Titel van presentatie datum van presentatie

8 1. GDP inspection process Inspection report Reply of the company with planned/ performed corrections Documented reply for the major remarks Review by the inspector(s) Closing inspection 8 Titel van presentatie datum van presentatie

9 1. Results of an GDP inspection Critical deficiency : significant departure/ risk for the patient Major deficiency : which indicates a (system)failure to carry out satisfactory procedures a combination of several other deficiencies, Minor deficiency : A deficiency, which cannot be classified as either critical or major, but which indicates a departure from GDP. 9 Titel van presentatie datum van presentatie

10 1. Results of an GDP inspection Not compliant with GDP - Critical shortcoming - Majors remarks (4>) - Warning letter / Stop activities? - Re inspection within a year Compliant with GDP after a positive PVA - less then 3/4 majors Compliant with GDP - zero remarks / minor shortcomings 10 Titel van presentatie datum van presentatie

11 1. Results of an GDP inspection GDP certificate after each positive GDP inspection of a wholesaler Given by Healthcare Authorities There are other GDP Certificates (commercial) 11

12 2. Results of GDP inspections Method 35 inspections during the first 6 months of 2014 what kind of companies? - wholesalers with full assortment - parallel wholesalers - logistic providers with warehousing - pharmaceutical wholesalers / exporters - manufacturers with wholesale activities 12

13 2. Results of 35 GDP inspections / topics Quality Management issues (1) Training / Responsible Person (2) Temperature management storage (3) Qualification suppliers / customers (5) Returns / Outsourcing (6/7) Self-inspection system (8) Transportation issues (9) 13

14 2. Management review Chapter 1 : A management review should be made based on analyses of the Quality registrations ; discussion with the management and proposal improvements. 14

15 2. Results of GDP inspections Results : Management review available : 58 %. SOP management review : 52 % Remarks : Management not always involved Not all quality information used Follow up improvements 15

16 2. Riskanalyses Chapter 1 : Risk analysis procedure and analysis of most important risks ;planned measures to reduce risks 16

17 2. Results of GDP inspections Results : Risk analyses performed : 48 % SOP risk analyses : 40 % Unknown : 10 % Remarks First risk analyses,not always based on method Discussion in team 17

18 2. Personnel,training, Responsibel Person Chapter 2 : GDP System for planning and registration GDP training for all involved personnel; training based on new GDP Guidelines; job description RP 18

19 2. Results of GDP inspections Results : System for GDP training : 81 %. Training new GDP Guideline : 54 % Description tasks RP : 69 % Remarks : 30 % of the RP s didn t follow new GDP training Some companies had planned new GDP training 19

20 2. Temperature management storage area Chapter 3 : monitoring, registration and control temperature storage area; alarm and follow-up ; mapping during summer and winter 20

21 2. Results of GDP inspections Results : Monitoring, registration, control : 94 %. Weak system : 18% Temperature mapping : 62 % Temperature mapping (S and W) : 27% Alarm system : 65 % Follow-up alarm :50 % Remarks : Sometimes only one device Sometimes temperature excursions without actions ; alarms on temperature monitoring device. 21

22 2. Qualification of suppliers (customers) Chapter 5 : Qualification of suppliers /customers based on authorization and other items ( i.e.questionnaire about quality status ) SOP should been in place. 22

23 2. Results of GDP inspections Results : Based on authorization : 97 %. Remarks : 35 % Based on questionnaire : 24 % Remarks : Licenses not always controlled and up to date Delivering to unauthorized clients 2 times. Check your performance yearly! 23

24 2. Results of GDP inspections Chapter 6 : System for handling and judging returned goods ; SOP available; based on new GDP Guidelines Results : System available /SOP : 90 %. Based on new GDP Guideline : 20 % Remarks : Responsible Person not always involved Criteria GDP Guideline not followed 24

25 2. Self-inspections Chapter 8 : Self-inspections should be planned and performed periodically; SOP 25

26 2. Results of GDP inspections (Self-inspections) Results : Operational system : 72 %. SOP : 90 % Follow up : 45% Remarks : Sometimes frequency too low. Don t forget QA. External audits are not the same Follow up by CAPA s 26

27 2. Transportation * Chapter 9 : Transportation outsourced,audits performed and contracts (QA,TA) available. 27

28 2. Results of GDP inspections (transportation) Results : Transportation outsourced : 77 %. Contracts available : 84 % Audits performed : 64 % Remarks : Use of sub-contracters with permission. Contracts not always based on new GDP Guideline Not always enough GDP appointments. 28

29 2. Finally The results of the first GDP inspections are reasonable Around 20 % was not compliant Weak points are : - Management review / risk analyses ( around 50%) - Handling returned goods - Qualification suppliers based on quality information. - Temperature mapping storage area - Follow up alarms, temperature excursions selfispections - Temperature mapping There is space for improvement! 29

30 30 Titel van presentatie datum van presentatie

MHRA GDP Symposium. Novotel London West, London 8 & 10 December #GMDPevents

MHRA GDP Symposium. Novotel London West, London 8 & 10 December #GMDPevents MHRA GDP Symposium Novotel London West, London 8 & 10 December 2015 Deficiencies in GDP Phil Neale, GDP Operations Manager Tony Orme, GDP Senior Inspector. Finding deficiencies in GDP is not only for those

More information

Overview SFLGDP1. Develop, implement and maintain a quality system to control the distribution of medicinal products

Overview SFLGDP1. Develop, implement and maintain a quality system to control the distribution of medicinal products Overview This standard is about developing, implementing and maintaining a quality system to control the. You will be responsible for developing the quality system and confirming colleagues understand

More information

Evaluation of Counterfeit Cases Impact of FMD & GDPs. Lorraine Nolan Healthcare Products Distribution Manager

Evaluation of Counterfeit Cases Impact of FMD & GDPs. Lorraine Nolan Healthcare Products Distribution Manager Evaluation of Counterfeit Cases Impact of FMD & GDPs Wholesale Distribution Information Day, 28th September 2012 Lorraine Nolan Healthcare Products Distribution Manager Slide 1 Contents 1. Review of UK

More information

UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products

UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products UNICEF Industry Consultation with Manufacturers and Suppliers of Finished Pharmaceutical Products 29 th 30 th September

More information

Overview SFLGDP1- HP Develop, implement and maintain a quality system to control the distribution of medicinal products

Overview SFLGDP1- HP Develop, implement and maintain a quality system to control the distribution of medicinal products - HP97 04 Overview What this standard is about This standard is about developing, implementing and maintaining a quality system to control the. You will be responsible for developing the quality system

More information

New GDP Guidelines - Implementation

New GDP Guidelines - Implementation New GDP Guidelines - Implementation Alfred Hunt, Inspector Wholesale Distribution Conference 11 th November 2014 New GDP Guidelines 2013/C 63/01-8 th September 2013 2013/C 343/01-5 th November 2013 2 1994

More information

Feedback from Inspection Programme

Feedback from Inspection Programme Feedback from Inspection Programme Wholesale Distribution Conference 8 th February 2017 Darren Scully Health Products Distribution Manager Wholesale distribution overview wholesale distribution procure

More information

Webinar Expert Module 3: GMP Inspections Dupont

Webinar Expert Module 3: GMP Inspections Dupont Webinar Expert Module 3: GMP Inspections Dupont 26 January & 9 February 2018 GOP-Innovations your Partner for Practical Training and e-learning Milenko Pavičić Pharmaceutical microbiologist, trainer, coach

More information

Healthcare Good Distribution Practice (GDP)

Healthcare Good Distribution Practice (GDP) Healthcare Good Distribution Practice (GDP) 10 March 2018 Copyright silverbacklogistics.com. All rights reserved The place to go for free supply chain advice 1 The role of the MHRA Ensuring that medicines

More information

Wholesaling & Distribution & the GMPs

Wholesaling & Distribution & the GMPs Wholesaling & Distribution & the GMPs Presented by Bryan Wright 11 th July 2016 Overview Wholesaling & distribution of Medicines (FPs) in the EU New EU GDP Guidelines Expectations How complicated can the

More information

Wholesaling & Distribution & the GMPs

Wholesaling & Distribution & the GMPs Wholesaling & Distribution & the GMPs Presented by Bryan Wright 11 th July 2016 Overview Wholesaling & distribution of Medicines (FPs) in the EU New EU GDP Guidelines Expectations How complicated can the

More information

MHRA GDP Symposium. Novotel London West, London 8 & 10 December #GMDPevents

MHRA GDP Symposium. Novotel London West, London 8 & 10 December #GMDPevents MHRA GDP Symposium Novotel London West, London 8 & 10 December 2015 Complex Business Models - Outsourced Activities Presented by: Jacqueline Masayi, GDP Inspector Background Increased complexities of the

More information

Management System Hilton Olympia, London 13 th February 2013

Management System Hilton Olympia, London 13 th February 2013 14. Building A Robust Quality Management System Hilton Olympia, London 13 th February 2013 Calcott Consulting consultant to the pharmaceutical & biotechnology industry Presenter s note Please note, the

More information

UNICEF Quality Assurance in the procurement of medicines

UNICEF Quality Assurance in the procurement of medicines UNICEF Quality Assurance in the procurement of medicines Peter S. Jakobsen 30 October 2006 Quality Assurance Centre SUPPLY DIVISION Today s presentation addresses 3 questions: How is UNICEF involved in

More information

Topics summarised in this presentation are: method for defining quality level you want meaning of external controls quality assurance activities

Topics summarised in this presentation are: method for defining quality level you want meaning of external controls quality assurance activities Topics summarised in this presentation are: method for defining quality level you want meaning of external controls quality assurance activities audit, audit report and CAPA 1. QUALITY must be guaranteed,

More information

Logistic Provider Qualification: prerequisites and SLA

Logistic Provider Qualification: prerequisites and SLA Logistic Provider Qualification: prerequisites and SLA Summary of the Content Benchmarking comparable providers and services to cope with product and market requirements Pre-qualification Activities Operational

More information

Overview sulla nuova guideline GDP

Overview sulla nuova guideline GDP AFTI 09 febbraio 2012 Overview sulla nuova guideline GDP Fabio Dotto Ispettorato Regionale Medicamenti Svizzera del Sud 1 113 GDP Guidelines GDP of Medicinal Products for Human Use Public consultation

More information

By Christoph Frick and Nicola Spiggelkötter. Creating a Master Plan for Drug Warehousing, Transportation and Distribution

By Christoph Frick and Nicola Spiggelkötter. Creating a Master Plan for Drug Warehousing, Transportation and Distribution By Christoph Frick and Nicola Spiggelkötter Creating a Master Plan for Drug Warehousing, Transportation and Distribution ISBN: 978-3-943267-93-8 Where a product trademark, registration mark, or other protected

More information

The list of certified companies may be consulted at ECOCERT Head office during regular office hours.

The list of certified companies may be consulted at ECOCERT Head office during regular office hours. P a g e 1 The list of certified companies may be consulted at ECOCERT Head office during regular office hours. ECOCERT holds at your disposal an "information for certification GLOBALGAP" questionnaire,

More information

Compliance with the GMP Standard in the International Level

Compliance with the GMP Standard in the International Level Compliance with the GMP Standard in the International Level 27 th August 2018 Chandrashekar Ranga Deputy Drugs Controller (India) CDSCO (HQ) 1 Outline Provisions under the Drugs and Cosmetics Act, 1940

More information

Prequalification Team WHO PUBLIC INSPECTION REPORT (WHOPIR) Active Pharmaceutical Ingredient (API) Manufacturer

Prequalification Team WHO PUBLIC INSPECTION REPORT (WHOPIR) Active Pharmaceutical Ingredient (API) Manufacturer Prequalification Team WHO PUBLIC INSPECTION REPORT (WHOPIR) Active Pharmaceutical Ingredient (API) Manufacturer PART 1: GENERAL INFORMATION Name of Manufacturer Calyx Chemicals & Pharmaceuticals Ltd Unit:

More information

V Final report. Final Report GMP inspection Hospira Enterprises B.V. Almere January 15, Utrecht, 2015

V Final report. Final Report GMP inspection Hospira Enterprises B.V. Almere January 15, Utrecht, 2015 1003920 2015-1167072 Final report Final Report GMP inspection Hospira Enterprises B.. Almere January 15, 2015 Utrecht, 2015 1003920 2015-1167072 Final report Report Reference no.: ame of product(s) and

More information

Agency and Internal Labeling

Agency and Internal Labeling Agency and Internal Labeling Audits Joseph McMillian, MA Heartland Compliance Services LLC Internal Labeling Audits The views and opinions expressed in the following PowerPoint slides are those of the

More information

Supplier Oversight PQRI. September Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan

Supplier Oversight PQRI. September Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan Supplier Oversight September 2014 PQRI Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan Agenda Mylan Background Setting the Stage with a Scenario Current State Thinking Supplier Qualification

More information

Pharmaceutical Good Manufacturing Practice. Contents are subject to change. For the latest updates visit

Pharmaceutical Good Manufacturing Practice. Contents are subject to change. For the latest updates visit Pharmaceutical Good Manufacturing Practice Page 1 of 6 Why Attend A robust quality system that meets the requirements of pharmaceutical regulators is an essential element of every good pharmaceutical manufacturing

More information

UNICEF Quality Assurance in the procurement of medicines

UNICEF Quality Assurance in the procurement of medicines UNICEF Quality Assurance in the procurement of medicines Peter S. Jakobsen October 2008 Quality Assurance Centre SUPPLY DIVISION 2 Today s presentation addresses 3 questions: How do UNICEF manage quality

More information

The APIC Audit Programme Version 5, July 2017

The APIC Audit Programme Version 5, July 2017 The APIC Audit Programme Version 5, July 2017 Table of contents 1 General 2. APIC Audit Programme 3 The Auditors 3.1 Educational Background and Experience 3.2 Auditor Training Courses for Certification

More information

GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE QA.APP.GEN-52 Laboratory Commodities and Consumables: Supplier Technical Questionnaire

GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE QA.APP.GEN-52 Laboratory Commodities and Consumables: Supplier Technical Questionnaire GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE Laboratory Commodities and Consumables: Supplier Technical Questionnaire This questionnaire is used to collect information from offerors of Laboratory Commodities

More information

Compounding Pharmacies and the Contract Testing Lab

Compounding Pharmacies and the Contract Testing Lab Compounding Pharmacies and the Contract Testing Lab Scott Sutton, Ph.D. scott.sutton@microbiol.org 1 Disclaimer I am making this presentation as an independent agent I am not making this presentation as

More information

QUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION

QUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PS/W 1/2011 2 Annexes 22 July 2011 QUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION PIC/S 2011 Reproduction

More information

MDSAP AUDIT PROCESS. A Manufacturer s Perspective. Connie Hoy EVP Regulatory Affairs Cynosure, Inc.

MDSAP AUDIT PROCESS. A Manufacturer s Perspective. Connie Hoy EVP Regulatory Affairs Cynosure, Inc. MDSAP AUDIT PROCESS A Manufacturer s Perspective Connie Hoy EVP Regulatory Affairs Cynosure, Inc. Cynosure Located in Westford, MA Largest manufacturer of Medical Lasers Second location in Hicksville,

More information

Preparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014

Preparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014 Preparing Your Aseptic Processing Facility for an FDA Inspection Valerie Welter, Director Quality Bayer HealthCare March 10, 2014 Agenda Regulatory Requirements Establishing your Approach Aseptic Controls

More information

PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT

PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT August 2010 RESTRICTED PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT Please address any comments on this draft guideline

More information

Quality Risk Management (QRM) of active pharmaceutical ingredients during transportation by using FMEA tools and methodology

Quality Risk Management (QRM) of active pharmaceutical ingredients during transportation by using FMEA tools and methodology PharmaTutor PRINT ISSN: 294-6679 E-ISSN: 247-788 2 Quality Risk Management (QRM) of active pharmaceutical ingredients during transportation by using FMEA tools and methodology Upendra Kumar Singh*, Sammer

More information

GUIDANCE FOR THE PREPARATION OF GOOD CLINICAL PRACTICE INSPECTION REPORTS

GUIDANCE FOR THE PREPARATION OF GOOD CLINICAL PRACTICE INSPECTION REPORTS EUROPEAN COMMISSION ENTERPRISE and INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals GUIDANCE DOCUMENTS CONTAINING THE COMMON PROVISIONS ON THE CONDUCT OF GCP INSPECTIONS BY COMPETENT AUTHORITIES

More information

CSV Inspection Readiness through Effective Document Control. Eileen Cortes April 27, 2017

CSV Inspection Readiness through Effective Document Control. Eileen Cortes April 27, 2017 CSV Inspection Readiness through Effective Document Control Eileen Cortes April 27, 2017 Agenda Background CSV Readiness CSV and Change Management Process Inspection Readiness Do s and Don ts Inspection

More information

Supersedes Division Name Revision No. 0 Export Division Page No. 1 of 9

Supersedes Division Name Revision No. 0 Export Division Page No. 1 of 9 Page No. 1 of 9 Control Status 1.0 Purpose To lay down a procedure for conducting GMP inspection and report writing for issue of Written Confirmation for for medicinal products for human. 2.0 Scope This

More information

Pharmacovigilance Inspection Metrics Report

Pharmacovigilance Inspection Metrics Report Pharmacovigilance Inspection Metrics Report April 2016 - March 2017 1. Introduction During the period 01 April 2016 to 31 March 2017, the GPvP Inspectorate conducted 36 inspections of marketing authorisation

More information

How does the GDP guidelines impacted DGF on Local and Global level. 25 june 2013

How does the GDP guidelines impacted DGF on Local and Global level. 25 june 2013 How does the GDP guidelines impacted DGF on Local and Global level. 25 june 2013 Overview Introduction Who is DHL? What is GDP? DGF services Global approach DGF services Belgium 2 Introduction Elledin

More information

Guide to Wholesaling and Brokering of Medicinal Products for Human Use in Ireland

Guide to Wholesaling and Brokering of Medicinal Products for Human Use in Ireland Guide to Wholesaling and Brokering of Medicinal Products for Human Use in Ireland IA-G0008-5 17 JUNE 2017 This guide does not purport to be an interpretation of law and/or regulations and is for guidance

More information

Quality System Regulation (QSR) Training

Quality System Regulation (QSR) Training Quality System Regulation (QSR) Training Or How to Ensure Development, Production and Sale of Safe, Effective, Consistent Product FDLI February 2003 Overview QSR History, Purpose and Scope Changes from

More information

Unofficial Translation

Unofficial Translation Unofficial Translation Manual of Auditing and Certification of Energy Management for Energy Auditor Manual of Auditing and Certification of Energy Management for Energy Auditor Department of Alternative

More information

Pharma and Logistic Service Providers (LSP) Synergies and opportunities GDP, NEW EUROPEAN DIRECTIVES

Pharma and Logistic Service Providers (LSP) Synergies and opportunities GDP, NEW EUROPEAN DIRECTIVES Pharma and Logistic Service Providers (LSP) Synergies and opportunities GDP, NEW EUROPEAN DIRECTIVES DB Schenker Healthcare Conference Europe April 17-18 th 2012 J. BERLO Industrial Pharmacist/Clin. Biol.

More information

CAPA Management: Best Practices and FDA QSR Mandate WHITE PAPER. ComplianceQuest In-Depth Analysis and Review

CAPA Management: Best Practices and FDA QSR Mandate WHITE PAPER. ComplianceQuest In-Depth Analysis and Review CAPA Management: Best Practices and FDA QSR Mandate WHITE PAPER ComplianceQuest In-Depth Analysis and Review CAPA Management: Best Practices and FDA QSR Mandate Establishing a corrective and preventive

More information

PREPARING A CLIENT FOR INVESTIGATIONS

PREPARING A CLIENT FOR INVESTIGATIONS PREPARING A CLIENT FOR INVESTIGATIONS INVESTIGATIONS Investigations Can Involve: - Industry or Sector Wide Investigation - Targeting a Company or Group of Companies - Unannounced Inspections ( Dawn Raids

More information

SUPPLIERS AND SUBCONTRACTORS

SUPPLIERS AND SUBCONTRACTORS Page: 1 of 8 SUPPLIERS AND ISSUE STATUS Issue Date: 11-04-2016 Issued for Use Revision Date: 30-01-2017 Revision No.: 1 Action Position Issued By: Reviewed By: Reviewed By: Approved By: QESH Document Controller

More information

QUALITY quality standard that the data are credible and the rights, safety, integrity and confidentiality of the subjects are protected HOW???

QUALITY quality standard that the data are credible and the rights, safety, integrity and confidentiality of the subjects are protected HOW??? L.Massad GCP an International Ethical and Scientific quality standard by which clinical trials are designed, implemented and reported so that there is public assurance that the data are credible and the

More information

GIRP-IPF Study 2016 KEY FINDINGS EUROPEAN HEALTHCARE DISTRIBUTION ASSOCIATION GROUPEMENT INTERNATIONAL DE LA RÉPARTITION PHARMACEUTIQUE

GIRP-IPF Study 2016 KEY FINDINGS EUROPEAN HEALTHCARE DISTRIBUTION ASSOCIATION GROUPEMENT INTERNATIONAL DE LA RÉPARTITION PHARMACEUTIQUE GIRP-IPF Study 2016 KEY FINDINGS EUROPEAN HEALTHCARE DISTRIBUTION ASSOCIATION GROUPEMENT INTERNATIONAL DE LA RÉPARTITION PHARMACEUTIQUE The role of the pharmaceutical wholesale sector 2 ROLE OF PHARMACEUTICAL

More information

Good Distribution Practices Toolkit. Quality Management System 08 March 2016

Good Distribution Practices Toolkit. Quality Management System 08 March 2016 Good Distribution Practices Toolkit Quality Management System 08 March 2016 1 Quality Policy GDP, Legal, Environmental, H&S Processes & Systems Resources Risk Assessments 2 Quality Policy & Objectives

More information

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer Part 1: General information Name of Manufacturer Production Block Physical address Contact address Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer. Clean Utilities in the Basement.

More information

Annex 4. Guidance on good manufacturing practices: inspection report. Background

Annex 4. Guidance on good manufacturing practices: inspection report. Background Annex 4 Guidance on good manufacturing practices: inspection report Background The need for revision of the Guidance on good manufacturing practices: inspection report (World Health Organization (WHO)

More information

Current Global GMP Status and Trends With Focus on EU & PIC/S JPMA Annual Meeting, Tokyo & Osaka, September 2012 Dr.-Ing.

Current Global GMP Status and Trends With Focus on EU & PIC/S JPMA Annual Meeting, Tokyo & Osaka, September 2012 Dr.-Ing. Current Global GMP Status and Trends With Focus on EU & PIC/S JPMA Annual Meeting, Tokyo & Osaka, September 2012 Dr.-Ing. Stephan Rönninger Pharma Medicines Technical Operations Global Quality & Compliance,

More information

WHO Prequalification Team (WHO-PQT) Introduction to medicines inspections technical updates

WHO Prequalification Team (WHO-PQT) Introduction to medicines inspections technical updates Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers of diagnostic products, vaccines, finished pharmaceutical products and active pharmaceutical ingredients WHO Prequalification Team (WHO-PQT)

More information

European Union (EU) Regulatory Trends in GMP. Clive Brading Tianjin, China September 23, 2009

European Union (EU) Regulatory Trends in GMP. Clive Brading Tianjin, China September 23, 2009 European Union (EU) Regulatory Trends in GMP Clive Brading Tianjin, China September 23, 2009 -2- Presentation Topics EU Background Inspections outside the EU EMEA Inspection Outcomes Dedicated Facilities

More information

Oursourcing and Supplier Qualification from the perspective of the pharmaceutical Industry

Oursourcing and Supplier Qualification from the perspective of the pharmaceutical Industry Oursourcing and Supplier Qualification from the perspective of the pharmaceutical Industry 1 Presentation Outline Pharmaceutical Quality Management Partner Selection and Qualification Shipping Qualification

More information

EURASIAN ECONOMIC COMMISSION COUNCIL

EURASIAN ECONOMIC COMMISSION COUNCIL EURASIAN ECONOMIC COMMISSION COUNCIL Working translation: DECISION October 9, 2014 No.94 Minsk On the Regulation on the Harmonized Procedure of Joint On-Site Inspections and of Taking Samples of Goods

More information

New Data Integrity Regulations and Practical Advice for Life Science Laboratories. we prove it.

New Data Integrity Regulations and Practical Advice for Life Science Laboratories. we prove it. 1 How to Meet New MHRA, FDA, EMA and WHO Data Integrity Guidelines white paper New Data Integrity Regulations and Practical Advice for Life Science Laboratories we prove it. 2 How to Avoid Poor Temperature

More information

Prequalification of Medicines Programme

Prequalification of Medicines Programme Prequalification of Medicines Programme SOP 408.4 Annex A WHO PUBLIC INSPECTION REPORT Finished Product Manufacturer WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: General

More information

Quality and GMP Compliance for Virtual Companies (Pharmaceutical, Medical Device & Biologics Industries)

Quality and GMP Compliance for Virtual Companies (Pharmaceutical, Medical Device & Biologics Industries) Quality and GMP Compliance for Virtual Companies (Pharmaceutical, Medical Device & Biologics Industries) *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! Today, many companies operate

More information

Taking a Leap Toward Global Supply Chain Efficiency - Part II

Taking a Leap Toward Global Supply Chain Efficiency - Part II Taking a Leap Toward Global Supply Chain Efficiency - Part II 2 Supply Chain Brochure - Part II INTRODUCTION Pharmaceutical manufacturers face a number of challenges in the production and delivery of medicinal

More information

GMP Track 1 Day 2 Session 1 Vendor Assurance

GMP Track 1 Day 2 Session 1 Vendor Assurance GMP Track 1 Day 2 Session 1 Vendor Assurance 11 August 2015 150403_POUT This session Three presentations Chapter 6 and 7 - Trevor Schoerie Quality Control Out sourced Activities Draft - FDA Quality Metrics

More information

Regulatory Requirements & Recent Changes, including expectations for APIs & IMPs

Regulatory Requirements & Recent Changes, including expectations for APIs & IMPs Regulatory Requirements & Recent Changes, including expectations for APIs & IMPs Neil Raw - GMP Inspector Richard Andrews - Operations Manager 11 th November 2008 Programme: Regulatory Requirements Neil

More information

Section 3 Company Organisation and Certification Procedures

Section 3 Company Organisation and Certification Procedures OF&G ORGANIC STANDARDS AND CERTIFICATION MANUAL 3.0 Contents Page The describe how the company is structured and administered, and explains the certification procedures, the complaints procedures and the

More information

GMP Inspection Process. Types of GMP Inspection. Module 18 Slide 1 of 14 WHO - EDM

GMP Inspection Process. Types of GMP Inspection. Module 18 Slide 1 of 14 WHO - EDM GMP Inspection Process Types of GMP Inspection Module 18 Slide 1 of 14 WHO - EDM Objectives 1. To review the different types of inspection 2. To examine when each is appropriate 3. To discuss inspections

More information

18.H Questionnaire for preparing GMP-inspections

18.H Questionnaire for preparing GMP-inspections Questionnaire for preparing -inspections Questionnaire for preparing -inspections Here you will find answers to the following questions: What questions are typically asked during inspections based on current

More information

ABSTRACT INTERNATIONAL LOGISTICS CRITERIA ON MEDICINAL PRODUCTS FOR HUMAN USE 1. INTRODUCTION. Shiang-Min Meng 1+ Hsiu-Yun Yang 2 Jane Dai 3

ABSTRACT INTERNATIONAL LOGISTICS CRITERIA ON MEDICINAL PRODUCTS FOR HUMAN USE 1. INTRODUCTION. Shiang-Min Meng 1+ Hsiu-Yun Yang 2 Jane Dai 3 International Journal of Asian Social Science ISSN(e): 2224-4441 ISSN(p): 2226-5139 DOI: 10.18488/journal.1.2019.92.148.168 Vol. 9, No. 2, 148-168 URL: www.aessweb.com INTERNATIONAL LOGISTICS CRITERIA

More information

Leading Practices on Compliance Series: Design History File (DHF): Tips for Creating a Successful DHF Tuesday, November 27, :00 1:00 pm Eastern

Leading Practices on Compliance Series: Design History File (DHF): Tips for Creating a Successful DHF Tuesday, November 27, :00 1:00 pm Eastern Leading Practices on Compliance Series: (DHF): Tips for Creating a Successful DHF Tuesday, November 27, 2012 12:00 1:00 pm Eastern Jack Ward, Senior Director Myraqa, Inc. Leading Practices on Compliance

More information

Journal of Chemical and Pharmaceutical Research

Journal of Chemical and Pharmaceutical Research Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research ISSN No: 0975-7384 CODEN(USA): JCPRC5 J. Chem. Pharm. Res., 2011, 3(6):88-98 Conduct of Inspections for Pharmaceutical Manufactures

More information

DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS

DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS GLOBAL PROVIDER, LOCAL SOLUTIONS IN YOUR LANGUAGE DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS Francesco Amorosi PhD Octorber 2017 DATA INTEGRITY & CSV:

More information

How to Survive an EBAA Site Inspection

How to Survive an EBAA Site Inspection How to Survive an EBAA Site Inspection Woodford S. Van Meter,MD Lexington, KY EBAA Site Inspections: Scheduled by Accreditation Board Approximately 15-20 eyebanks inspected every six months Individual

More information

Applying a Knowledge-Based Approach to Pharmaceutical Supply Chain Temperature Control Management

Applying a Knowledge-Based Approach to Pharmaceutical Supply Chain Temperature Control Management May 1-3, 2012 Javits Center New York, NY Applying a Knowledge-Based Approach to Pharmaceutical Supply Chain Control Management Arminda O. Montero Program Manager, Distribution QA Global Pharmaceutical

More information

Could Poor Temperature Data Management be Putting Your GxP Facility at Risk for Data Integrity Violations? we prove it.

Could Poor Temperature Data Management be Putting Your GxP Facility at Risk for Data Integrity Violations? we prove it. 1 How to Meet New MHRA, FDA and WHO Data Integrity Guidelines WHITE PAPER Could Poor Temperature Data Management be Putting Your GxP Facility at Risk for Data Integrity Violations? we prove it. 2 How to

More information

Addressing Key FDA Citations with Training. Align UL EduNeering Courses to Top FDA Warning Letter Topics

Addressing Key FDA Citations with Training. Align UL EduNeering Courses to Top FDA Warning Letter Topics Addressing Key FDA Citations with Training Align UL EduNeering Courses to Top FDA Warning Letter Topics Addressing Key FDA Citations with Training Align UL EduNeering Courses to Top FDA Warning Letter

More information

AUDIT REPORT. Audit of Offi cial Controls carried out by the Local Authority Veterinary Service Cavan County Council

AUDIT REPORT. Audit of Offi cial Controls carried out by the Local Authority Veterinary Service Cavan County Council AUDIT REPORT Audit of Offi cial Controls carried out by the Local Authority Veterinary Service AUDIT REPORT Audit of Official Controls carried out by the Local Authority Veterinary Service TABLE OF CONTENTS

More information

Outsourcing - managing risks and opportunities over which you now have less control

Outsourcing - managing risks and opportunities over which you now have less control Outsourcing - managing risks and opportunities over which you now have less control Kevin O Donnell, PhD PDA Meeting, Dublin 22 nd November 2018 Slide 2 Typical Examples The key GMP Requirements & Guidance

More information

Guide to Good Distribution Practice of Medicinal Products for Human Use

Guide to Good Distribution Practice of Medicinal Products for Human Use Guide to Good Distribution Practice of Medicinal Products for Human Use IA-G0046-3 9 NOVEMBER 2017 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes

More information

Conducting and reporting a GCP Inspection. Gunnar Danielsson Medical Products Agency

Conducting and reporting a GCP Inspection. Gunnar Danielsson Medical Products Agency Conducting and reporting a GCP Inspection Gunnar Danielsson Medical Products Agency Preparation for an inspection Inspection plan Create worksheets for the inspection general project specific study specific

More information

Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Tablets

Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Tablets Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: information about the inspection Name of manufacturer Physical address production departments

More information

EKOTAR Programme Manual Organic Production Instruction Contracting

EKOTAR Programme Manual Organic Production Instruction Contracting Page 1 / 6 Contracting, registration and resignation of a client 1. Scope and aim This document is additional to the General Program manual and describes in detail how to act from the first contact with

More information

Computer System Validation - Reduce Costs and Avoid 483s

Computer System Validation - Reduce Costs and Avoid 483s Computer System Validation - Reduce Costs and Avoid 483s *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! This Computer System Validation Training course will explore proven techniques

More information

Guide to Quality System for General Sale Wholesale Distributors

Guide to Quality System for General Sale Wholesale Distributors Guide to Quality System for General Sale Wholesale Distributors IA-G0038-5 20 DECEMBER 2017 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only.

More information

Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs)

Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs) Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs) *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! The globalization of the pharmaceutical

More information

Embracing a Culture of Self Correction

Embracing a Culture of Self Correction Embracing a Culture of Self Correction Making the Most of Internal Audit Programs Julie Larsen Principal, BioTeknica Where I have been ASCP Certified Medical Technologist Introduction Rush St. Luke s Presbyterian

More information

2012 Academy Seminar - Thessaloniki, Greece Storage and transportation of pharmacy compounded drugs

2012 Academy Seminar - Thessaloniki, Greece Storage and transportation of pharmacy compounded drugs 2012 Academy Seminar - Thessaloniki, Greece Storage and transportation of pharmacy compounded drugs 21 April 2012, Barbara Wimmer, barbara.wimmer@gespag.at Conflict of interest: nothing to disclose 1.

More information

Summary of differences between Bonsucro/Bonsucro EU RED mass balance CoC standard and Draft of revised Bonsucro CoC standard 16 October 2018

Summary of differences between Bonsucro/Bonsucro EU RED mass balance CoC standard and Draft of revised Bonsucro CoC standard 16 October 2018 Summary of differences between Bonsucro/Bonsucro EU RED mass balance CoC standard and Draft of revised Bonsucro CoC standard Title: Bonsucro chain of custody standard Title: Bonsucro/Bonsucro EU RED mass

More information

New GMPs for Active Substances & Excipients. Presented by Eoin Hanley 4 July, 2016

New GMPs for Active Substances & Excipients. Presented by Eoin Hanley 4 July, 2016 New GMPs for Active Substances & Excipients Presented by Eoin Hanley 4 July, 2016 What we will cover in this session The changing landscape EC Guideline on principles of GDP of active substances Formalised

More information

Supplier Questionnaire and On-site Supplier Evaluation

Supplier Questionnaire and On-site Supplier Evaluation Supplier Questionnaire and On-site Supplier Evaluation GENERAL EVALUATION INSTRUCTIONS Purpose Application This On-site Supplier Evaluation (OSE) is to assess the supplier's ability to produce a quality

More information

The Impact of Quality Culture on Quality Risk Management. FDA Perspective on Quality Culture; how it Impacts Risk Management

The Impact of Quality Culture on Quality Risk Management. FDA Perspective on Quality Culture; how it Impacts Risk Management The Impact of Quality Culture on Quality Risk Management FDA Perspective on Quality Culture; how it Impacts Risk Management Teresa Gorecki Practice Lead Compliance Architects Agenda The WHAT Definitions

More information

ISCC Integrity Program

ISCC Integrity Program ISCC PLUS 254 Integrity Program ISCC Integrity Program ISCC PLUS 254 V 1.0 Copyright notice ISCC 2012 This ISCC document is protected by copyright. It is freely available from the ISCC website or upon

More information

CLICK TO ADD TITLE [SPEAKERS NAMES]

CLICK TO ADD TITLE [SPEAKERS NAMES] CLICK TO ADD TITLE [SPEAKERS NAMES] [DATE] Thanks to our generous sponsors Increasing access to essential medicines through pre-qualified, quality local sources Stephen Kimatu Partnership for Supply Chain

More information

PHARMACY, MEDICINES & POISONS BOARD GUIDELINES FOR RECALL OF MEDICINES AND HEALTH PRODUCTS IN MALAWI

PHARMACY, MEDICINES & POISONS BOARD GUIDELINES FOR RECALL OF MEDICINES AND HEALTH PRODUCTS IN MALAWI PHARMACY, MEDICINES & POISONS BOARD GUIDELINES FOR RECALL OF MEDICINES AND HEALTH PRODUCTS IN MALAWI Draft September 2015 1. INTRODUCTION The Malawi Pharmacy Medicines and Poisons Board (PMPB) was established

More information

Quality Systems and GMPin Pharmaceutical Manufacturing. Marleine Akl Quality Assurance Algorithm SAL

Quality Systems and GMPin Pharmaceutical Manufacturing. Marleine Akl Quality Assurance Algorithm SAL Session s Outline 1. Bio-equivalence 2. A 30-minute DVD on GMP Break 3. Quality Systems and GMPs in Pharmaceutical Manufacturing 4. Good Distribution Practices 5. Questionnaire (could not go through due

More information

Self-Inspection and its potential benefits via ICH Q9 & Q10

Self-Inspection and its potential benefits via ICH Q9 & Q10 Self-Inspection and its potential benefits via ICH Q9 & Q10 Kevin O Donnell, Ph.D. Senior Inspector & Market Compliance Manager Irish Medicines Board IMB Information Day October 23 rd, 2008 Slide 1 Topics

More information

The FDA Just Arrived... Are You Ready? Presented By Sandra Lueken Sr. Director, Quality AstraZeneca Biologics

The FDA Just Arrived... Are You Ready? Presented By Sandra Lueken Sr. Director, Quality AstraZeneca Biologics The FDA Just Arrived... Are You Ready? Presented By Sandra Lueken Sr. Director, Quality AstraZeneca Biologics Objectives Review Quality Systems Audit Approach and cgmp fundamentals Logistical Audit Preparation

More information

Supplier Qualification and Regulatory Compliance in International Biopharm Logistics. November 19 th, Copenhagen, 2015

Supplier Qualification and Regulatory Compliance in International Biopharm Logistics. November 19 th, Copenhagen, 2015 Supplier Qualification and Regulatory Compliance in International Biopharm Logistics November 19 th, Copenhagen, 2015 Pharmaceutical Quality Management Partner Selection and Qualification Outsourcing and

More information

White paper Audits in automated production

White paper Audits in automated production White paper Audits in automated production data management for automation Introduction: Audits in automated production In the field of production management, audits have become an important tool for analysing

More information

AUDIT REPORT. Audit of Offi cial Controls carried out by the Local Authority Veterinary Service Louth County Council

AUDIT REPORT. Audit of Offi cial Controls carried out by the Local Authority Veterinary Service Louth County Council AUDIT REPORT Audit of Offi cial Controls carried out by the Local Authority Veterinary Service AUDIT REPORT Audit of Official Controls carried out by the Local Authority Veterinary Service TABLE OF CONTENTS

More information

UPPLIER ANUAL. Issued: 01 Aug 13

UPPLIER ANUAL. Issued: 01 Aug 13 UPPLIER ANUAL Issued: 01 Aug 13 Table of Contents Our Company 3 Our Vision 3 Scope and Purpose 4 Responsibilities 4 General Expectations and Requirements 5 Supplier Quality Management System 6 Supplier

More information

Your Partner Of Choice For Global Pharma Compliance. Corporate Presentation

Your Partner Of Choice For Global Pharma Compliance. Corporate Presentation Your Partner Of Choice For Global Pharma Compliance. Corporate Presentation Vision We aspire to be a partner of choice for global compliance & project management across the pharmaceutical value chain,

More information

Review of HPRA Draft Guide to Distribution of Medical Devices, including in vitro diagnostic Medical Devices

Review of HPRA Draft Guide to Distribution of Medical Devices, including in vitro diagnostic Medical Devices Review of HPRA Draft Guide to Distribution of Medical Devices, including in vitro diagnostic Medical Devices Ref: IA-G0004-x Summary DCC Vital welcomes the new draft guidance which will provide clarity

More information